Leila Kiefer, PhD, is a Clinical Protocol Development Associate for UNC Lineberger Comprehensive Cancer Center at the University of North Carolina Chapel Hill. Leila assists investigators in developing various documents associated with clinical trial development and maintenance including letters of intent, initial clinical trials protocols, and protocol amendments. Leila also acts as a liaison between pharmaceutical companies and the principal investigators, as needed, during trial development and during the life of the study. Leila drafts patient-facing materials including informed consent forms and performs quality assurance activities for both consent documents and clinical protocols.
Previously, Leila served as a Grant Writing Specialist/Scientific Consultant for Eva Garland Consulting, a Lab Director at Wood Hudson Cancer Research, and a Quality Control Chemist at Bayer Pharmaceuticals. Leila completed a four year postdoctoral research fellowship at Cincinnati Children’s Hospital Medical Center in the Division of Pediatric General and Thoracic Surgery specializing in Pediatric Liver Oncology. Leila received her PhD in Pharmaceutical Sciences from the University of Rhode Island, her MS in Pharmaceutical Sciences from North Carolina Central University and BS in Food Science from North Carolina State University.